The Most Important Voice Is Missing: The Case For Including Patient Insights In Protocol Design
Most Recent Flipbooks
Supporting Value Across the Regulatory Submission Continuum
Should You Be Adjudicating Your Clinical Endpoints?
Immunology Trials: Innovation Brings Hope, Fresh Challenges
Delivering CNS Trials Requires Specialized Clinical Knowledge
More Than Good Intentions: Diversity, Equity & Inclusion Requires a Program-Level, Strategic Framework
The Top 5 Benefits of Outsourcing Expert Committee Management to an Independent Provider
The Challenge of Overreporting: A Fresh Perspective from the FDA
In a recent webinar, Steven Beales, Senior VP, Scientific and Regulatory at WCG, facilitated a conversation with FDA leaders, discussing overreporting SUSARs and the impact on patient safety.
Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial
Workforce Preparedness - A Proven Method to De-Risk Your Development
Reinventing Site Feasibility- Breaking Away From a Failed Status Quo
Q&A: A Fresh Perspective from the FDA on the Final IND Safety Reporting Rule
Big Challenges for Small Sponsors: Competition in Oncology Research
Don't Do It Alone: To De-Risk Your Next Trial, Seek Outside Expertise
Whitepaper - WCG Predict Analysis of MDD Study
Save the Data. Protect the Patients. Prepare for What Comes Next.
WCG CRCs Equip Sites With Tailored Support
Whitepaper - The Power of More Re-Imagining the Traditional Business Model for Oncology Clinical Research
WCG Virtual Study Training eBook
WCG Trends & Insights for 2021
Developing Annual Reports for Research Organizations